Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications
The FASEB Journal · 15.07.2024 · 38 (13)
DOI: 10.1096/fj.202400839r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 09.07.2024. Verfasst von Vipin Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Hypertension, Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, …. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Cardiovascular Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Regulatory T cells (Tregs) are crucial in regulating T‐cell‐mediated immune responses. Numerous studies have shown that dysfunction or decreased numbers of Tregs may be involved in inflammatory cardiovascular diseases (CVDs) such as atherosclerosis, hypertension, myocardial infarction, myocarditis, cardiomyopathy, valvular heart diseases, heart failure, and abdominal aortic aneurysm. Tregs can help to ameliorate CVDs by suppressing excessive inflammation through various mechanisms, including inhibition of T cells and B cells, inhibition of macrophage‐induced inflammation, inhibition of dendritic cells and foam cell formation, and induction of anti‐inflammatory macrophages. Enhancing or restoring the immunosuppressive activity of Tregs may thus serve as a fundamental immunotherapy to treat hypertension and CVDs. However, the precise molecular mechanisms underlying the Tregs‐induced protection against hypertension and CVDs remain to be investigated. This review focuses on recent advances in our understanding of Tregs subsets and function in CVDs. In addition, we discuss promising strategies for using Tregs through various pharmacological approaches to treat hypertension and CVDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Hypertension, Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease, Yanbian University Hospital, Yanji, Jilin, P.R. China.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Vipin Kumar, Megumi Narisawa, Xian Wu Cheng
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Kumar, V., Narisawa, M., & Cheng, X. W. (2024). Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications. The FASEB Journal, 38(13). https://doi.org/10.1096/fj.202400839r
Vancouver
Kumar V, Narisawa M, Cheng XW. Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications. The FASEB Journal. 2024;38(13). doi:10.1096/fj.202400839r
BibTeX
@article{Kumar2024,
author = {Kumar, Vipin and Narisawa, Megumi and Cheng, Xian Wu},
title = {Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {13},
doi = {10.1096/fj.202400839r}
}
EUVIMED